Tag: Ravulizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ravulizumab

FDA Action Update, April 2022: Extensions, Approvals, and Designations - Neurology Live

Added to Collection on: 2022-05-04 18:52:45

Tags for this article:

Life Sciences
Biotechnology
Monoclonal antibodies
Health care
Orphan drugs
Alnylam Pharmaceuticals
Therapeutic gene modulation
Food and Drug Administration
Spinal muscular atrophy
Aducanumab
Ravulizumab
Biogen

Click the tags to see associated articles and topics

View Article Details
Paroxysmal Nocturnal Hemoglobinuria Therapeutics Market Future Business Opportunities ...

Added to Collection on: 2022-07-14 12:06:50

Tags for this article:

Life Sciences
Health care
Health
Alexion Pharmaceuticals
AstraZeneca
Ravulizumab
Hemoglobinuria
Paroxysmal attack
Pharmaceutical industry in China
Paroxysmal hemoglobinuria

Click the tags to see associated articles and topics

View Article Details
EMA panel backs Amgen/AstraZeneca's asthma drug Tezspire; Ultomiris for expanded use

Added to Collection on: 2022-07-22 13:46:13

Tags for this article:

Life Sciences
Health care
Health sciences
Orphan drugs
Monoclonal antibodies
AstraZeneca
Medical research
Södertälje Municipality
European Medicines Agency
GMG
Ravulizumab
Amgen

Click the tags to see associated articles and topics

View Article Details
Pfizer: Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY ...

Added to Collection on: 2022-09-19 07:24:41

Tags for this article:

Health
Articles
Committee for Medicinal Products for Human Use
European Medicines Agency
CHMP
Pfizer
Marketing authorization
Ravulizumab
Lorlatinib
BioNTech SE
Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Ultomiris gets approval in EU to treat rare neuromuscular disorder

Added to Collection on: 2022-09-23 08:34:27

Tags for this article:

Organ systems
Branches of biology
Nervous system
Quaternary ammonium compounds
RTT
GMG
Neuromuscular junction
Acetylcholine receptor
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Acetylcholine
Myasthenia gravis
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca's Ultomiris approved in EU for myasthenia gravis - Morningstar

Added to Collection on: 2022-09-23 07:58:10

Tags for this article:

Autoimmune diseases
Organ systems
Monoclonal antibodies
Myasthenia gravis
RTT
Quaternary ammonium compounds
Drugs
Companies
Myasthenia
AstraZeneca
Ravulizumab
Acetylcholine
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca's Ultomiris approved in EU for myasthenia gravis

Added to Collection on: 2022-09-23 19:25:25

Tags for this article:

Autoimmune diseases
Organ systems
Monoclonal antibodies
Drugs
Myasthenia gravis
RTT
Quaternary ammonium compounds
Companies
Myasthenia
AstraZeneca
Ravulizumab
Acetylcholine
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Alexion's Ultomiris approved in Europe for gMG - DirectorsTalk Interviews

Added to Collection on: 2022-09-23 07:08:30

Tags for this article:

Organ systems
Life Sciences
Biotechnology
Alexion Pharmaceuticals
RTT
Monoclonal antibodies
Atypical hemolytic uremic syndrome
Myasthenia gravis
AstraZeneca
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
GMG
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG

Added to Collection on: 2024-04-15 20:56:51

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Autoimmune diseases
Eculizumab
Myasthenia gravis
Rare diseases
Ravulizumab
Apheresis
Atypical hemolytic uremic syndrome

Click the tags to see associated articles and topics

View Article Details
Safety Considerations for Ravulizumab in NMOSD: Sean Pittock, MD - NeurologyLive

Added to Collection on: 2024-04-23 19:08:11

Tags for this article:

Monoclonal antibodies
Orphan drugs
Autoimmune diseases
Rare diseases
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Multiple sclerosis
Aquaporin-4
Ravulizumab
Therapy

Click the tags to see associated articles and topics

View Article Details